Bridging the Breast Cancer Awareness Gap: Insights from a Pan-European Survey A newly released survey, sponsored by Daiichi Sankyo and AstraZeneca, underscores the urgent need for more accessible and accurate information about breast cancer. Conducted across five major European countries…
Pepto-Bismol The Ultimate Solution for Five Common Digestive Issues Did you know that gastrointestinal (GI) issues affect a significant portion of the UK population each year? Research indicates that approximately 60% of adults in the UK experience some form of…
Cagent Vascular Announces the Launch of Serranator SL-PRO™ for Pedal and Tibial Disease Treatment Cagent Vascular a leader in the development of cutting-edge serration technology for vessel dilation in endovascular procedures, has unveiled its latest innovation: the Serranator SL-PRO™ PTA…
Reports Algiax Pharmaceuticals Announces Positive Phase 2a Results for AP-325 in Neuropathic Pain Reports Algiax Pharmaceuticals, a clinical-stage biotechnology company dedicated to developing innovative therapies for chronic neuropathic pain, has announced compelling topline results from its Reports Phase 2a proof-of-concept…
Cosette Pharmaceuticals a leading specialty pharmaceuticals company, has announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. This strategic move comes as the company continues its expansion in the generics market, reinforcing its commitment to leadership excellence…
Bayer has officially submitted a marketing authorization application to the European Medicines Agency (EMA), seeking approval for the use of finerenone in adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40% or greater. This…
Inhalon Biopharma a clinical-stage biotechnology company focused on developing innovative treatments for acute respiratory infections (ARI), has announced a major milestone in the advancement of its inhaled antibody platform. The company has successfully completed Investigational New Drug (IND)-enabling studies for…
Ethris Reports Promising Phase 1 Data for mRNA Candidate ETH47 in Asthma Ethris GmbH, a pioneering biotechnology company specializing in next-generation RNA therapeutics and vaccines, has unveiled encouraging topline data from the completed Phase 1 clinical trial of its lead…
40 Years of Excellence in Laser Technology Quanta System proudly celebrates a major milestone in 2025-40 years of pioneering innovation in laser technology. Since its founding in 1985, it has been at the forefront of developing cutting-edge laser solutions for…
Enveric Biosciences Secures Patent Protection for Breakthrough Neuroplastogen EB-003 In a significant milestone for its innovative drug development pipeline, Enveric Biosciences (NASDAQ: ENVB) has announced the receipt of a Notice of Allowance (NOA) from the United States Patent and Trademark…
RevBio Secures 10th Patent for TETRANITE®: Expanding Protection for Revolutionary Bone Adhesive Technology In a significant milestone for regenerative medicine, ITS, a clinical-stage medical device company, has been granted its 10th U.S. patent for its groundbreaking TETRANITE® bone adhesive technology.…
The global Pharmaceutical R&D Outsourcing market is set to grow significantly, with a valuation of USD 84.01 billion in 2023 and expected to reach USD 150.04 billion by 2029, representing a compound annual growth rate (CAGR) of 10.15%. This growth…